Oncologists' Cost Sensitivity May Drive Biosimilar Uptake
March 9th 2021
By Tony Hagen
ArticleSonia T. Oskouei, PharmD, BCMAS, DPLA, vice president of Biosimilars at Cardinal Health, discusses motivating factors that affect use of biosimilars in oncology.